Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page
- Check4 days agoChange DetectedRecruitment status updated to indicate that enrollment has ended. The version history was updated to include Revision: v3.6.0 and remove Revision: v3.5.5.SummaryDifference0.5%

- Check11 days agoChange DetectedA new revision v3.5.5 was added to the version history and the older v3.5.4 entry was removed from the visible history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision entry for v3.5.4 was added to the Record History, replacing the previous v3.5.3 in the history log.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page version/revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor interface or system update without changing the study record content.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision v3.5.2 has been added and the previous revision v3.5.0 has been removed.SummaryDifference0.1%

- Check90 days agoChange DetectedA new record version v3.5.0 was added and the previous version v3.4.3 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.